SENSOR DISORDERS AT MULTIPLE SCLEROSIS AND MEANS OF THEIR CORRECTION BY THIOCTIC ACID



Cite item

Full Text

Abstract

Thioctic acid usage was scientifically proved for the purpose of sensor disorders' correction in patients with multiple sclerosis. There was evaluated effectiveness of therapy by thioctic acid in the multiple sclerosis patients, having different sensor disorders as seen after postregistered clinical investigations. According to the preliminary results it was shown that thioctic acid can positively influence sensor disorders.

About the authors

Farit А Khabirov

1) Каzan State Medical Academy of Russian Health Ministry, 2) Republican Clinical-and-Diagnostic Centre for demyelinization diseases of Health Ministry of the Republic of Tatarstan

1) Каzan State Medical Academy of Russian Health Ministry, 2) Republican Clinical-and-Diagnostic Centre for demyelinization diseases of Health Ministry of the Republic of Tatarstan

Radij G Esin

1) Каzan State Medical Academy of Russian Health Ministry, 2) Republican Clinical-and-Diagnostic Centre for demyelinization diseases of Health Ministry of the Republic of Tatarstan

1) Каzan State Medical Academy of Russian Health Ministry, 2) Republican Clinical-and-Diagnostic Centre for demyelinization diseases of Health Ministry of the Republic of Tatarstan

Тimur I Khaibullin

1) Каzan State Medical Academy of Russian Health Ministry, 2) Republican Clinical-and-Diagnostic Centre for demyelinization diseases of Health Ministry of the Republic of Tatarstan

Email: timuur@gmail.com
1) Каzan State Medical Academy of Russian Health Ministry, 2) Republican Clinical-and-Diagnostic Centre for demyelinization diseases of Health Ministry of the Republic of Tatarstan

Аlexander А Rogozhin

1) Каzan State Medical Academy of Russian Health Ministry, 2) Republican Clinical-and-Diagnostic Centre for demyelinization diseases of Health Ministry of the Republic of Tatarstan

1) Каzan State Medical Academy of Russian Health Ministry, 2) Republican Clinical-and-Diagnostic Centre for demyelinization diseases of Health Ministry of the Republic of Tatarstan

Natalya N Babicheva

Republican Clinical-and-Diagnostic Centre for demyelinization diseases of Health Ministry of the Republic of Tatarstan

Republican Clinical-and-Diagnostic Centre for demyelinization diseases of Health Ministry of the Republic of Tatarstan

Ludmila A Аverjanova

1) Каzan State Medical Academy of Russian Health Ministry, 2) Republican Clinical-and-Diagnostic Centre for demyelinization diseases of Health Ministry of the Republic of Tatarstan

1) Каzan State Medical Academy of Russian Health Ministry, 2) Republican Clinical-and-Diagnostic Centre for demyelinization diseases of Health Ministry of the Republic of Tatarstan

Еvgeny V Granatov

1) Каzan State Medical Academy of Russian Health Ministry, 2) Republican Clinical-and-Diagnostic Centre for demyelinization diseases of Health Ministry of the Republic of Tatarstan

1) Каzan State Medical Academy of Russian Health Ministry, 2) Republican Clinical-and-Diagnostic Centre for demyelinization diseases of Health Ministry of the Republic of Tatarstan

References

  1. Котов, С.В. Тиоктацид в лечении больных РС в период обострений / С.В. Котов, И.Г. Рудакова, В.Ю. Лиждвой // Лечение нервных болезней. - 2003. - Т.4, № 2 (10). - С. 17-19.
  2. Марков, Д.А. Рассеянный склероз / Д.А. Марков, А.Л. Леонидович. - Медицина, 1976. - 296 c.
  3. Рассеянный склероз: избранные вопросы теории и практики [под ред. И.А. Завалишина, В.И. Головкина]. - М., 2000. - 640 c.
  4. Хабиров, Ф.А. Рассеянный склероз. Современные аспекты диагностики и лечения: учеб. пособие для врачей / Ф.А. Хабиров, Р.Г. Есин, О.С. Кочергина и др. - Казань, 2007. - 48 c.
  5. Calabrese, V. NO synthase and neurodegenerative disorders: the role of oxidant/antioxidant balance / V. Calabrese, T.E. Bates, A.M. Stella // Neurochem. Res. - 2000. - Vol. 25 (9-10). - P. 1315-1341.
  6. Cosi, C. Poly (ADP-ribose) polymerase: early involvement in glutamate - induced neurotoxicity in cultured cerebellar granule cells / C. Cosi, H. Suzuki, D. Milani et al. // Neurosci. Res. - 1994. - Vol. 39 (1). - P. 38-46.
  7. Salinthone, S. Lipoic acid: a novel therapeutic approach for multiple sclerosis and other chronic inflammatory diseases of the CNS / S. Salinthone, V. Yadav, D.N. Bourdette et al. // Endocrine, Metabolic and Immune Disorders. Drug Targets. - 2008. - Vol. 8. - P. 132-142.
  8. Kararizou, E. Stereoanesthesia or astereognosia? / E. Kararizou, D. Lykomanos, A. Kosma et al. // Neurol. Sci. - 2009. - Vol. 30 (5). - P. 409-411.
  9. Lincoln, N.B. Reliability and Revision of the Nottingham Sensory Assessment for Stroke Patients / N.B. Lincoln, J.M. Jackson, S.A. Adams // Physiotherapy. - 1998. - Vol. 84. - P. 358-365.
  10. Numasawa, Y. Pseudoradicular sensory loss caused by a cerebral demyelinative lesion / Y. Numasawa, T. Irioka, H. Mizusawa // Intern. Med. - 2008. - Vol. 47 (13). - P. 1287-1288.
  11. Osterberg, A. Central pain in multiple sclerosis - sensory abnormalities / A. Osterberg, J. Boivie // Eur. J. Pain. - 2010. - Vol. 14 (1). - P. 104-110.
  12. Rae-Grant, A.D. Sensory symptoms of multiple sclerosis: a hidden reservoir of morbidity / A.D. Rae-Grant, N.J. Eckert, S. Bartz, J.F. Reed // Mult. Scler. - 1999. - Vol. 5 (3). - P. 179-183.
  13. Yoshida, T. Effect of methylprednisolone-pulse therapy on superoxide production of neutrophils / T. Yoshida, M. Tanaka, A. Sotomatsu, K. Okamoto // Neurol. Res. - 1999. - Vol. 21 (5). - P. 509-512.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2010 Khabirov F.А., Esin R.G., Khaibullin Т.I., Rogozhin А.А., Babicheva N.N., Аverjanova L.A., Granatov Е.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 75562 от 12 апреля 2019 года.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies